Dendritic cell vaccine hits FDA roadblock.
Genentech Inc., USA.
Thomas
T
Morrow
D001324:Autoantigens / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000494:pharmacology*; D003713:Dendritic Cells; D017277:Drug Approval; D006801:Humans; D008222:Lymphokines / Q000276:immunology; D008297:Male; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D014020:Tissue Extracts / Q000276:immunology / Q000494:pharmacology*; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D014481:United States; D014486:United States Food and Drug Administration
D001324:Autoantigens; D019496:Cancer Vaccines; D008222:Lymphokines; D014020:Tissue Extracts; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; C022780:allogenic effect factor; C511774:sipuleucel-T